The Ethics of Right to Try Investigational Agents in Oncology—Balancing Hope With Evidence

This Viewpoint discusses the ethical implications of Right to Try access to investigational oncology agents for patients and physicians.

Authors

Institutions

Publication Details

Journal
JAMA Oncology
Published
2026-01-08
DOI
https://doi.org/10.1001/jamaoncol.2025.5771
Primary Topic
Biomedical Ethics and Regulation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Ethics of Right to Try Investigational Agents in Oncology—Balancing Hope With Evidence

Xudong Zhu, Yue Wang, Lihui Yan, Xiangyu Zhu
JAMA Oncology
Biomedical Ethics and Regulation
article

The Ethics of Right to Try Investigational Agents in Oncology—Balancing Hope With Evidence

Xudong Zhu, Yue Wang, Lihui Yan, Xiangyu Zhu
article en

Abstract

This Viewpoint discusses the ethical implications of Right to Try access to investigational oncology agents for patients and physicians.

JAMA OncologyVol. 12(3)
Liaoning Cancer Hospital & Institute (CN)
Peace, Justice and strong institutions
Openalex Percentile: Top 94%
Biomedical Ethics and Regulation
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The Ethics of Right to Try Investigational Agents in Oncology—Balancing Hope With Evidence — Xudong Zhu, Yue Wang, et al. · JAMA Oncology (2026) | TGRS Research Map | TGRS